Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,272,470
-$223,672 QoQ
Shares Held
20,881
-8.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#333
of 1,603 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CLOVERFIELDS CAPITAL GROUP, LP holds $3,272,470 across 1 Drug Manufacturers - General name. NVS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
20,881 | $3,272,470 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,272,470 | 20,881 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,496,142 | 22,888 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,271,792 | 23,731 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,386,802 | 18,612 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,480,099 | 20,495 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,151,006 | 19,295 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,885,673 | 19,378 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,090,833 | 18,178 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $1,253,868 | 13,629 | Shares | Sole | 2023-09-07 | |
| 2022-12-31 | $561,193 | 6,186 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||